UBS fuels Delek rise

Delek, is 74%-owned by Yitchak Tshuva, though Wolf believes a recent sale of a 2.8% stake by Tshuva could boost liquidity.

By SUSAN LERNER
January 10, 2006 07:17
1 minute read.
delek english logo 88

delek english logo 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Shares of Delek Group rose 1.4 percent to NIS 713.80 Monday fueled by comments from UBS analyst Joseph Wolf, who initiated coverage of the stock with a "buy" recommendation and a NIS 820 price target. "We see three reasons to own the stock: Exposure to the Israeli economy, exposure to a successful management team; and underappreciated value of privately held assets, especially the US fuel business," Wolf wrote in a note to clients. "We see significant upside potential in the US fuel operations as investors become more familiar with the opportunity there. We also like the positioning of the auto and real estate holdings," Wolf said. The company, he noted, is active in the energy, automotive, real estate, fuel operations, biochemical, and telecommunications sectors, and also recently entered the financial services segment in Israel. Delek, is 74%-owned by Yitchak Tshuva, though Wolf believes a recent sale of a 2.8% stake by Tshuva could boost liquidity. Although public holdings account for 88% of market cap, Wolf said he sees upside coming from non-public assets.



More about:Israel

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS